RBC Bioscience Overview

  • Status
  • Public

  • Employees
  • 47

Employees

  • Stock Symbol
  • 6848

Stock Symbol

  • Share Price
  • $0.61
  • (As of Friday Closing)

RBC Bioscience General Information

Description

RBC Bioscience Corp is a bio-sciences company. Its products include the manufacture and sale of molecular biological medical diagnosis and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3F., No.132, Ln. 235, Baoqiao Road
  • Xindian Dist
  • New Taipei, 231-45
  • Taiwan
+886 02
Primary Industry
Discovery Tools (Healthcare)
Stock Exchange
ROCO
Corporate Office
  • 3F., No.132, Ln. 235, Baoqiao Road
  • Xindian Dist
  • New Taipei, 231-45
  • Taiwan
+886 02

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RBC Bioscience Stock Performance

As of 20-Jun-2025, RBC Bioscience’s stock price is $0.61. Its current market cap is $7.89M with 13M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.61 $0.60 $0.48 - $0.76 $7.89M 13M 15.9K $0.05

RBC Bioscience Financials Summary

As of 31-Dec-2024, RBC Bioscience has a trailing 12-month revenue of $6.4M.

In Thousands,
USD
TTM 31-Dec-2024 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022
EV 20,057 20,057 20,358 20,761
Revenue 6,396 6,396 5,537 5,841
EBITDA 1,709 1,709 1,179 1,077
Net Income 672 672 206 127
Total Assets 23,230 23,230 24,531 25,769
Total Debt 14,550 14,550 15,861 16,444
Public Fundamental Data provided by Morningstar, Inc. disclaimer

RBC Bioscience Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RBC Bioscience‘s full profile, request access.

Request a free trial

RBC Bioscience Patents

RBC Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160017314-A1 Method for isolating nucleic acids from formalin-fixed paraffin embedded tissue samples Inactive 06-Jun-2013
US-20140364597-A1 Method for isolating nucleic acids from formalin-fixed paraffin embedded tissue samples Inactive 06-Jun-2013
EP-2811022-A1 Method for isolating nucleic acids from formalin-fixed paraffin embedded tissue samples Inactive 06-Jun-2013
DE-202013102057-U1 Device for extracting nucleic acids by means of magnetic beads Inactive 10-May-2013
EP-2805987-A1 Method for manufacturing magnetic particle composite Inactive 18-Jan-2012 C08J3/215
To view RBC Bioscience’s complete patent history, request access »

RBC Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RBC Bioscience FAQs

  • Where is RBC Bioscience headquartered?

    RBC Bioscience is headquartered in New Taipei, Taiwan.

  • What is the size of RBC Bioscience?

    RBC Bioscience has 47 total employees.

  • What industry is RBC Bioscience in?

    RBC Bioscience’s primary industry is Discovery Tools (Healthcare).

  • Is RBC Bioscience a private or public company?

    RBC Bioscience is a Public company.

  • What is RBC Bioscience’s stock symbol?

    The ticker symbol for RBC Bioscience is 6848.

  • What is the current stock price of RBC Bioscience?

    As of 20-Jun-2025 the stock price of RBC Bioscience is $0.61.

  • What is the current market cap of RBC Bioscience?

    The current market capitalization of RBC Bioscience is $7.89M.

  • What is RBC Bioscience’s current revenue?

    The trailing twelve month revenue for RBC Bioscience is $6.4M.

  • What is RBC Bioscience’s annual earnings per share (EPS)?

    RBC Bioscience’s EPS for 12 months was $0.05.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »